Clinical TrialsSearch results
Number of results: 279
Other
- Phase III Clinical Study on Taste Disorder by Z-103 -Double Blind Comparison Study on Patients with Zinc-Deficient and Idiopathic Taste Disorders -
- Zinc-Deficient and Idiopathic Taste Disorders
- ZERIA Pharmaceutical Co.,Ltd.
- 2006-04-10
Other
- Prevention of early asthma in childhood trial with pranlukast in Mie; PROACT-Mie
- Wheezing syndrome in infants
- Study group of pediatric asthma in Mie prefecture
- 2009-05-01
Other
- Clinical study of Prevention and Actual situation of Venous Thromboembolism after Total Arthroplasty
- Venous Thromboembolism Osteoarthrosis
- National Hospital Organization
- 2008-09-11
Other
- A phase I/II study of concurrent chemoradiation with irinotecan hydrochloride(CPT-11) and cisplatin(CDDP) for uterine cervical cancer. (KCOG 0328)
- Uterine cervical cancer
- Kansai Clinical Oncology Group (KCOG)
- 2005-09-16
Other
- A phase I/II study of concurrent chemoradiotherapy with irinotecan for advanced or recurrent uterine cancer
- uterine cancer (squamous cell carcinoma, adeno- and/or adenosquamous cell carcinoma, endometrial carcinoma, carcinosarcoma)
- National Hospital Organization Kobe Medical Center
- 2005-09-09
Recruiting
- Robot-assisted para-aortic lymph node dissection for uterine cancer with lymph node metastasis
- uterine cancer
- Kondo Eiji
- 2023-08-01
Recruiting
- Robot-assisted para-aortic lymph node dissection for uterine cancer
- uterine cancer
- Kondo Eiji
- 2021-08-04
Other
- Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- untreated stage IV or relapsed/refractory NK/T-cell lymphoma
- NK-cell Tumor Study Group
- 2007-06-18
Other
- Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE)
- Untreated essential hypertensive patients
- HOMED-BP Study Group
- 2005-09-09
Other
- A multicenter, observational study for reactivation of hepatitis B virus by means of serial HBV-DNA monitoring during and just after systemic chemotherapy containing rituximab plus steroid for malignant lymphoma (C-SHOT 0802)
- Untreated CD20-positive, B-cell non-Hodgkin's lymphoma in the patients with seronegativity for HBsAg and seropositivity for HBc-Ab and/or HBs-Ab, which is planned to be treated with 6-8 courses of systemic chemotherapy containing rituximab plus steroid such as R-CHOP, R-CVP, R-THP-COP and R-C-MOPP
- Nagoya City University Hospital
- 2008-08-11